Fibrocell Science, Inc. 4
4 · Fibrocell Science, Inc. · Filed Mar 2, 2016
Insider Transaction Report
Form 4
Pernock David
Director
Transactions
- Award
Option to Purchase Common Stock
2016-03-01+425,000→ 425,000 totalExercise: $2.27Exp: 2026-03-01→ Common Stock (425,000 underlying)
Footnotes (2)
- [F1]The options set forth in this table vest as follows: 106,250 vesting on March 1, 2017 and 318,750 vesting in 12 equal quarterly installments beginning on June 1, 2017 and ending on March 1, 2020, subject to the grantee's continued service.
- [F2]The options were issued in connection with the reporting person's employment service to the Company.